ARCHIVES

FDA Plans Safety Reviews Of Newly Approved Drugs; Drug Safety Bills Introduced In Senate.

This article is from The Cancer Letter archive.

Vol. 33 No. 04 | February 2, 2007

Download PDF Visit The Full Archive

Related Articles

Conversation with The Cancer Letter: Kazerooni: The Case for Broad Coverage

March 21, 2014

NCI Seeks Applications For Small Business Research Awards

February 28, 1997

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

June 24, 2011

Susan Horwitz Succeeds Waun Ki Hong As AACR President

April 12, 2002

FDA Proposes To Drop Specific Requirements For Reprint Distribution On Off-Label Uses.

February 22, 2008

Senate Committee Proposes $301 Million Increase For NIH

September 22, 1995